BioTelemetry, the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple to provide cardiac monitoring services in conjunction with the Apple Heart Study. The study, which launched today, is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation, using the Apple Watch and the dedicated "Apple Heart Study" App.

Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: "We are extremely excited to be participating in this potentially ground-breaking study. Too often, the first indication of a cardiac arrhythmia is the occurrence of a life-threatening event. The Apple initiative will potentially benefit countless individuals who are unaware that they may be at risk for serious health issues."

When it rains it pours. Earlier today Patently Apple also posted a report covering the FDA approving a new EKG Reader in the form of an Apple Watch Band that detects abnormal heart rhythm and AFib that will work with Apple's Heart Study App.

About Making Comments on our Site: Patently Apple reserves the right to post, dismiss or edit any comments. Those using abusive language or negative behavior will result in being blacklisted on Disqus.